Explore the latest studies, experimental protocols, and scientific breakthroughs in apoptosis mechanisms
Explore BR101801, a novel triple-inhibitor therapy targeting PI3Kγ, PI3Kδ, and DNA-PK for advanced hematologic malignancies. Learn about preclinical insights and clinical trial results.